Long-term Outcomes in Patients With COVID-19
NCT04508712 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900
Last updated 2020-10-23
Summary
Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.
Conditions
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Weifeng Yu, MD,PhD · Renji Hospital, School of Medicine, Shanghai Jiaotong University, China
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-10
- Primary Completion
- 2021-08-31
- Completion
- 2021-08-31
Countries
- China
Study Locations
More Related Trials
-
Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)
NCT04586413 ·Status: RECRUITING
-
Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)
NCT04350073 ·Status: COMPLETED
-
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167 ·Status: ENROLLING_BY_INVITATION
-
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19
NCT05771857 ·Status: COMPLETED
-
Liver Health and Metabolic Function in People With Obesity
NCT03701828 ·Status: COMPLETED ·Phase: NA
-
Neurological Impact of Weight Reduction and Fitness Interventions
NCT06830252 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China
NCT04573283 ·Status: RECRUITING
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
NCT05421572 ·Status: UNKNOWN
-
The Liver Health Study for Patients with NAFLD
NCT03151798 ·Status: COMPLETED ·Phase: NA
-
The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution
NCT05416970 ·Status: COMPLETED
-
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797 ·Status: COMPLETED
-
Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults
NCT05306678 ·Status: COMPLETED ·Phase: NA
-
The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
NCT06061640 ·Status: UNKNOWN
-
Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
NCT05729269 ·Status: COMPLETED
-
Evaluation of Body Iron Stores in Overweight Healthy Volunteers
NCT02304874 ·Status: COMPLETED ·Phase: NA
-
Intermittent Fasting for NAFLD in Adults
NCT04899102 ·Status: RECRUITING ·Phase: NA
-
Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
NCT05560997 ·Status: UNKNOWN
-
RF Based QIMT & QAS Study on Chinese Adults
NCT04881292 ·Status: UNKNOWN
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease
NCT04463667 ·Status: UNKNOWN ·Phase: NA
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD
NCT07233486 ·Status: RECRUITING ·Phase: NA
-
Effect of Diet Composition on Liver Fat and Glucose Metabolism
NCT00930371 ·Status: COMPLETED ·Phase: NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT05332613 ·Status: RECRUITING ·Phase: NA